R Squared’s Insmed INSM Stock Holding History

R Squared’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40	Closed	-$2.76K	–	871
2024 Q4	$2.76K	Buy	+40	New	+$2.88K	﹤0.01%	1424

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

R Squared's INSM Position: Q1 2025 in Review

R Squared sold out of Insmed (INSM) in Q1 2025, closing a stake of 40 shares — an estimated $2.76K sold.

R Squared first reported a position in INSM in Q4 2024 and held it in 1 quarter. The position peaked at $2.76K in Q4 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

R Squared reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
R Squared sold 40 Insmed shares in Q1 2025, an estimated $2.76K.
R Squared first reported a position in Insmed in Q4 2024 and held it in 1 quarter.
R Squared's Insmed position peaked at $2.76K in Q4 2024.
441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.